On July 16, 2025, an incident involving nutritional supplements was reported through the Rapid Alert System for Food and Feed portal (RASFF). The report indicated the detection of Ganoderma lucidum in these supplements originating from the United Kingdom. This incident falls under the category of control and highlights concerns regarding the safety and quality of nutritional products available to consumers.
Ganoderma lucidum, also known as reishi mushroom, is a fungus that has been used in traditional medicine for various purposes. The presence of this substance in nutritional supplements may raise questions about ingredient transparency and regulatory compliance. Monitoring agencies are tasked with ensuring that products on the market meet safety standards and do not contain unauthorized or harmful components.
The detection of Ganoderma lucidum in these supplements may prompt further investigation by health authorities to assess the extent of the issue and determine the appropriate course of action. Consumers are advised to stay informed about product safety alerts and to consult relevant regulatory bodies for updates regarding the status of the affected supplements.